# Predictheon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/predictheon

- Industry: Healthcare IT
- Headquarters: Barcelona, Spain
- Website: www.predictheon.com/
- Total disclosed funding: $1M
- Latest round: Seed (May 5, 2021)
- Investors on record: 1

## About

Predictheon develops predictive monitoring solutions to improve patient safety and health outcomes in healthcare settings through advanced algorithms integrated into clinical technologies.Predictheon, founded in 2019 in Barcelona, Spain, focuses on predictive monitoring for healthcare. The company was established by Jose Valencia and Pedro Gambus, the latter serving as CEO. In February 2026, Predictheon raised EUR 1.8 million in venture funding. Predictheon specializes in predictive monitoring solutions designed to enhance patient safety and health outcomes across various healthcare settings. Their core offerings include algorithms that utilize advanced mathematical models, which are integrated into software operating on clinical monitors, infusion pumps, and electronic health records. Key products, such as the PDA monitor and general anesthesia insights, provide real-time, continuous patient data, predicting clinically relevant outcomes 3-5 minutes ahead of time. By delivering personalized information about anesthetic medication effects, these solutions aim to prevent adverse events and optimize decision-making during the perioperative period. Predictheon serves a diverse client base of hospitals, surgical centers, and healthcare providers primarily in North America and Europe.Predictheon generates revenue through a business-to-business (B2B) model, offering their predictive monitoring solutions to healthcare institutions. Transactions are structured around software licensing and service agreements, allowing clients to access Predictheon’s technology and support on a subscription basis. Revenue for the most recent year, 2022, is recorded at EUR 0.00, with an EBITDA of EUR -230,143.20, reflecting the company's current financial status as it develops its offerings.Following a Seed funding round in May 2021, Predictheon plans to utilize the EUR 840,000 raised to develop real-time software solutions aimed at predicting changes in patient conditions and clinically relevant adverse events. The company will use the February 2026, funding to advance commercialization, secure regulatory approvals, and conduct upcoming clinical trials.

## Funding rounds

- Seed, May 5, 2021, $1M — Clave Capital

## Investors

- Clave Capital — Seed